• $2.8M
    Market Cap
  • 128.55%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-63,981
-65.20%
-183,867
-57.78%
-435,449
-58.47%
-1.0M
-28.00%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
6,200
N/A
N/A
N/A
Total Operating Expenses
616,119
-29.96%
879,655
-37.16%
1.4M
-46.73%
2.6M
-24.95%
Operating Profit
-616,119
-29.96%
-879,655
-37.16%
-1.4M
-46.73%
-2.6M
N/A
Interest Income
6
+20.00%
5
-99.85%
3,408
+10,227.27%
33
-8.33%
Interest Expense
-10,001
+43.82%
-6,954
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-9,995
+43.83%
-6,949
-303.90%
3,408
+10,227.27%
33
-8.33%
Total Nonoperating Income and Expense
-69,327
+73.63%
-39,928
-110.14%
393,933
+58.17%
249,052
+237.66%
Income before Taxes
-685,446
-25.46%
-919,583
-8.58%
-1.0M
-57.71%
-2.4M
N/A
Income Taxes
2,400
0.00%
2,400
0.00%
2,400
0.00%
2,400
0.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-1.0M
-57.65%
-2.4M
-35.38%
Net Income from Continuing Operations Applicable to Common
-685,446
-25.46%
-919,583
-8.58%
-1.0M
-57.71%
-2.4M
N/A
Basic EPS and Net Income
-0.10
-23.08%
-0.13
-7.14%
-0.14
-57.58%
-0.33
-40.00%
Diluted EPS and Net Income
-0.10
-23.08%
-0.13
-7.14%
-0.14
-57.58%
-0.33
-40.00%
Basic Weighted Average Shares
7.2M
0.00%
7.2M
0.00%
7.2M
+0.01%
7.2M
+7.79%
Diluted Weighted Average Shares
7.2M
0.00%
7.2M
0.00%
7.2M
+0.01%
7.2M
+7.79%
Balance Sheet
Cash and Cash Equivalents
3,622
-96.85%
115,019
-26.35%
156,178
-29.22%
220,645
-2.43%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3,622
-96.85%
115,019
-26.35%
156,178
-29.22%
220,645
-2.43%
Total Current Assets
19,882
-85.96%
141,611
-21.12%
179,533
-31.29%
261,277
-3.05%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
19,882
-85.96%
141,611
-21.12%
179,533
-31.29%
261,277
-3.05%
Income Taxes Payable
6,214
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
200,000
0.00%
200,000
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.0M
+8.90%
5.5M
+16.99%
4.7M
+20.81%
3.9M
+67.90%
Total Long-Term Debt
1.5M
+5.27%
1.4M
+5.69%
1.3M
+7.26%
1.2M
+67.09%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
7.5M
+8.17%
6.9M
+14.53%
6.1M
+17.58%
5.1M
+67.70%
Retained Earnings
-9.5M
+7.78%
-8.8M
+11.65%
-7.9M
+14.59%
-6.9M
+52.59%
Total Stockholders Equity
-7.5M
+10.13%
-6.8M
+15.62%
-5.9M
+20.19%
-4.9M
+74.52%
Total Shares Outstanding
7.2M
0.00%
7.2M
0.00%
7.2M
0.00%
7.2M
+0.01%
Cash Flow
Cash from Operating Activities
-111,397
-53.81%
-241,159
-51.52%
-497,467
-27.92%
-690,129
+1.60%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
0
-100.00%
433,000
+26.24%
343,000
+1,141.09%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
0
-100.00%
200,000
N/A
0
-100.00%
341,632
-34.93%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-457.45%
-49.01%
-897.14%
-11.46%
Return on Equity
N/A
N/A
N/A
N/A
18.75%
-69.75%
61.97%
-72.91%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.003
-87.11%
0.03
-32.45%
0.04
-43.18%
0.07
-42.25%
Cash Ratio
0.0006
-97.12%
0.02
-36.97%
0.03
-41.39%
0.06
-41.90%
Debt-to-Equity Ratio
-0.22
-5.03%
-0.23
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
83.79
+645.06%
11.25
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow